Company intelligence / Profile preview

Freecurve Labs

San Francisco, California, United Statesfreecurve.com ↗

Ownership: Private
Development stage: Preclinical

Overview

Freecurve Labs has developed breakthrough technology in molecular modeling that allows accurate prediction of properties and behaviors of complex systems. Their tools are currently used by academic collaborators and national labs. They are engaged with commercial partners across biotech, materials science, minerals, and energy sectors. No clinical results as they do not run clinical trials themselves.

Modalities: Small moleculeAntibody
Industry: Drug Discovery Services

Partnerships

Academic collaboratorsNational labsCommercial partners in biotech/materials/minerals/energy sectors

Beyond the preview

Go deeper on Freecurve Labs.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Freecurve Labs.

Explore the full profile